產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-CCDC104抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-CCDC104抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CCDC104
Cat. Number:
Anti-CCDC104抗體KL-8103R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
CCDC104 is a 342 amino acid protein that exists as two alternatively spliced isoforms. CCDC104 undergoes post-translationalAnti-CCDC104抗體 phosphorylation following DNA damage, most likely by either ATR or ATM. The gene encoding CCDC104 maps to human chromosome 2, the second largest human chromosome, which consists of 237 million bases, encodes over 1,400 genes and makes up approximately 8% of the human genome. A number of genetic diseases are linked to genes on chromosome 2. Harlequin icthyosis, a rare and morbid skin deformity, is associated with mutations in the ABCA12 gene. The lipid metabolic disorder sitosterolemia is associated with ABCG5 and ABCG8. An extremely rare recessive genetic disorder, Alstr syndrome is due to mutations in the ALMS1 gene.
Also known as:
CC104_HUMAN; Anti-CCDC104抗體CCDC104; Coiled coil domain containing 104; Coiled-coil domain-containing protein 104; MGC15407.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CCDC104.
●
Predicted Molecular Weight: 39kDa.
Storage:
Shipped at 4℃, Anti-CCDC104抗體Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working Anti-CCDC104抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-CCDC104抗體dilutions must be determined by the end user.
kl553Mu01 基質(zhì)金屬蛋白酶9(MMP9)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 9 (MMP9)
kl553Po01 基質(zhì)金屬蛋白酶9(MMP9)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 9 (MMP9)
kl553Ra01 基質(zhì)金屬蛋白酶9(MMP9)多克隆抗體 Polyclonal Antibody to Matrix Metalloproteinase 9 (MMP9)
kl554Ra01 尼克酰胺腺嘌呤二核苷酸磷酸氧化酶1(NOX1)多克隆抗體 Polyclonal Antibody to Nicotinamide Adenine Dinucleotide Phosphate Oxidase 1 (NOX1)
kl556Hu01 角蛋白7(KRT7)多克隆抗體 Polyclonal Antibody to Keratin 7 (KRT7)
kl557Hu01 甲狀腺過(guò)氧化物酶(TPO)多克隆抗體 Polyclonal Antibody to Thyroid Peroxidase (TPO)
kl557Ra01 甲狀腺過(guò)氧化物酶(TPO)多克隆抗體 Polyclonal Antibody to Thyroid Peroxidase (TPO)
kl558Hu01 端粒酶關(guān)聯(lián)蛋白1(TEP1)多克隆抗體 Polyclonal Antibody to Telomerase Associated Protein 1 (TEP1)
kl559Hu01 腸型脂肪酸結(jié)合蛋白(FABP2)多克隆抗體 Polyclonal Antibody to Fatty Acid Binding Protein 2, Intestinal (FABP2)
kl559Mu01 腸型脂肪酸結(jié)合蛋白(FABP2)多克隆抗體 Polyclonal Antibody to Fatty Acid Binding Protein 2, Intestinal (FABP2)
kl559Ra01 腸型脂肪酸結(jié)合蛋白(FABP2)多克隆抗體 Polyclonal Antibody to Fatty Acid Binding Protein 2, Intestinal (FABP2)
kl561Mu01 白血病抑制因子受體(LIFR)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
kl561Ra01 白血病抑制因子受體(LIFR)多克隆抗體 Polyclonal Antibody to Leukemia Inhibitory Factor Receptor (LIFR)
kl563Bo01 白介素1β(IL1β)多克隆抗體 Polyclonal Antibody to Interleukin 1 Beta (IL1b)
kl563Ca01 白介素1β(IL1β)多克隆抗體 Polyclonal Antibody to Interleukin 1 Beta (IL1b)
kl563Eq01 白介素1β(IL1β)多克隆抗體 Polyclonal Antibody to Interleukin 1 Beta (IL1b)
